A graduate of Yale University (Master of Science at the Faculty of Biology) and Hamilton College (Bachelor of Arts), he also studied at the Faculty of Biochemistry of the Imperial College of Science Technology and Medicine (University of London). He has an MBA diploma from IESE Business School (Universidad de Navarra).
 
Founder and partner, and until November 2016, President of the Management Board of Biocorp Polska Sp. z o.o., a company that is a manufacturer of microbiological diagnostic tests, which merged with BioMaxima SA.

He has many years of experience in the capital market. From September 2021, a member of the Advisory Board at PFR Life Science, a special purpose vehicle of the Polish Development Fund Group, whose activity focuses on investments in the biotechnology sector, in selected companies, in particular seeking sources of funding for clinical trials. From 2020, a member of the Investment Committee and the Board of Experts of PFR Ventures, the largest fund manager in Central and Eastern Europe (over 50 funds, PLN 2.5 billion under management). In the years 2013-2019 he was a member, including in 2016-2019 the chairman of the Investment Committee of the National Capital Fund S.A. In the years 2006-2009 he was the vice president and financial director at PZU Asset Management. Previously, he worked in London at 3i Investments plc, a private equity fund management company. he co-created the strategy in the healthcare sector. He was a judge of the Arbitration Court at the National Depository for Securities.

Previously, he also held positions in management and supervisory bodies of other capital companies. He also has many years of consulting experience. He is a member of the American scientific honorary societies Phi Beta Kappa and Sigma Xi. He is fluent in English and Spanish.